Company Profile
Updated: 13-AUG-09Cise S.R.L.
International Private company
Alicia M. De Justo 1120, Of. 306 A, Capital Federal, Capital Federal, C1107AAR, Argentina
()54 1147116401, 54 1147116401 fax, http://www.cise.com.ar
Primary SIC: Computer Facilities Management Service, Primary NAICS: Computer Facilities Management Services
Description: Computer Facilities Management Service
View this company profile - Now for a Limited Time, try Goliath Company Profiles
Free for 3 Days!
exercise
The Oxford Pocket Dictionary of Current English; 1/27/2009; 411 words; ex·er·cise / ˈeksərˌsīz / • n. 1. activity requiring physical effort, carried...xB7;er·cis·a·ble / -əbəl / adj.
U.S. Patents Awarded to Inventors in Utah (June 27)
Targeted News Service; 6/27/2008; 1248 words; ...limit the electrode's current densities...inventors were issued U.S. Patent No. 7,367...2Fsrchnum.htm&r=1&f=G&l=50&s1=7...June 27 -- David Cise of Herriman, Utah...According to the U.S. Patent & Trademark...
Utah Inventors Develop Occluder for Preventing Infusion Flow
US Fed News Service, Including US State News; 6/27/2008; 437 words; ...June 27 -- David Cise of Herriman, Utah...According to the U.S. Patent & Trademark...inventors were issued U.S. Patent No. 7,367...2Fsrchnum.htm&r=1&f=G&l=50&s1=7...9199 (in the U.S. or Canada) or 703...
8 Utah patents include biomedical devices
Deseret News (Salt Lake City); 6/3/2008; 688 words; ...infusion line. David Cise, Herriman; David...D. Isaacson, Paul R. Borgmeier, all of...Holladay; Thomas R. Giallorenzi, Riverton. Assigned to L-3 Communications...369,606. Karl R. Cannon is a registered...for $3 each from U.S. Patent and Trademark...
PRESIDENTIELLES FRANEcAISES:L'espoir du changement dans la continuitE[umlaut].
The Star (Amman, Jordan); 5/5/2007; 1933 words; ...en premier e. DE s le 2 juin, dans...2l qui a voulu l'assimiler Ea de l'antisE[umlaut...lite, sE[c]r de lui-mE[logical...bien prE[umlaut]cise sous Chirac.Mais...on tabler sur l'histoire pour...alors qu'il s'agit d'une affaire...
Recent News Articles
- Teva presents results from the PreCISe trial.(Clinical report)
Pharma Marketletter - September 29, 2008 - Positive results from Teva's PreCISe Copaxone study.
Pharma Marketletter - April 28, 2008 - Early Treatment with COPAXONE(R) Demonstrated Robust Protection against Progression to Clinically Definite Multiple Sclerosis in the PreCISe Study.
Business Wire - December 03, 2007 - Slim, Trim, or Tone this Summer with the Hottest New Lifestyle Trend -- Bog-er-cise(TM).
PR Newswire - June 12, 2007
Why Purchase This Company Profile?
- Sales prospecting
- Competitive analysis
- Vendor & supplier evaluation
- Customer evaluation and analysis
- Strategic planning